Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1873
https://www.valueinhealthjournal.com/article/S1098-3015(16)33239-9/fulltext
Title : Cost-Effectiveness of Insulin Degludec/Insulin Aspart (IDEGASP) Compared with Biphasic Insulin Aspart (BIASP 30) in Patients with Type 2 Diabetes Mellitus from a Mexican Healthcare Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33239-9&doi=10.1016/j.jval.2016.09.1873
First page : A672
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1772
Categories :
Tags :
Regions :
ViH Article Tags :